Molecular Diagnostics

Background

Molecular diagnostics methods can be employed in a number of areas.
The term molecular diagnostics is not clearly defined and partly overlaps with other technologies such as in vitro or polymerase chain reaction (PCR) based diagnostics.
In the 90's molecular diagnostics made a number of advancements and many tests have become standard methods.
Since 2000, molecular diagnostics has gained in importance - also in non-clinical areas.
In 2006, a market study was carried out to obtain a better understanding of the situation, perspectives and future trends.
 

Core Messages

  • Progressive knowledge of the genomic makes new approaches possible.
  • Geno typing and validation of biomarkers will open new applications.
  • New analysis targets or methods can further enhance the potential of molecular diagnostics, simplify the application and allow for more reliable statements.
  • Miniaturisation and automation will lead to the development of analysis devices which can be operated also by  untrained personnel (lab-on-a-chip).
  • Biosensors have high potential in the environmental diagnostics sector.
  • Molecular diagnostics methods offer the possibility to obtain more accurate and quicker results compared to  conventional diagnostics or analytical methods.
  • With the molecular diagnostics method illnesses can be detected earlier and a more accurate analysis of the  causes is possible resulting in tailor-made therapies and cost savings.
  • In pharmaceutics, prognoses can be made about the effects of active ingredients or medicines.
  • The global molecular diagnostics market is expected to grow 5x that of the current market by 2015.
     

© FOUNDING ANGELS 2010

Terms of Use       Privacy Policy       Disclaimer       Site map    Imprint